These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20056349)

  • 1. Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the university of tsukuba.
    Nakayama H; Sugahara S; Tokita M; Satoh H; Tsuboi K; Ishikawa S; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):467-71. PubMed ID: 20056349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.
    Hata M; Tokuuye K; Kagei K; Sugahara S; Nakayama H; Fukumitsu N; Hashimoto T; Mizumoto M; Ohara K; Akine Y
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):786-93. PubMed ID: 17379439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer.
    Iwata H; Murakami M; Demizu Y; Miyawaki D; Terashima K; Niwa Y; Mima M; Akagi T; Hishikawa Y; Shibamoto Y
    Cancer; 2010 May; 116(10):2476-85. PubMed ID: 20225229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton beam therapy of Stage II and III non-small-cell lung cancer.
    Nakayama H; Satoh H; Sugahara S; Kurishima K; Tsuboi K; Sakurai H; Ishikawa S; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):979-84. PubMed ID: 20888140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose proton beam therapy for Stage I non-small-cell lung cancer.
    Nihei K; Ogino T; Ishikura S; Nishimura H
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):107-11. PubMed ID: 16458447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy.
    Haasbeek CJ; Lagerwaard FJ; Antonisse ME; Slotman BJ; Senan S
    Cancer; 2010 Jan; 116(2):406-14. PubMed ID: 19950125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study.
    Baumann P; Nyman J; Hoyer M; Gagliardi G; Lax I; Wennberg B; Drugge N; Ekberg L; Friesland S; Johansson KA; Lund JS; Morhed E; Nilsson K; Levin N; Paludan M; Sederholm C; Traberg A; Wittgren L; Lewensohn R
    Radiother Oncol; 2008 Sep; 88(3):359-67. PubMed ID: 18768228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
    Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
    Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy.
    Fang LC; Komaki R; Allen P; Guerrero T; Mohan R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):108-16. PubMed ID: 16904517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).
    Dunlap NE; Larner JM; Read PW; Kozower BD; Lau CL; Sheng K; Jones DR
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):583-9. PubMed ID: 20478576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: results of a 12-year experience at Loma Linda University Medical Center.
    Bush DA; Cheek G; Zaheer S; Wallen J; Mirshahidi H; Katerelos A; Grove R; Slater JD
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):964-8. PubMed ID: 23845845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome.
    van der Voort van Zyp NC; Prévost JB; Hoogeman MS; Praag J; van der Holt B; Levendag PC; van Klaveren RJ; Pattynama P; Nuyttens JJ
    Radiother Oncol; 2009 Jun; 91(3):296-300. PubMed ID: 19297048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer.
    Zhao L; West BT; Hayman JA; Lyons S; Cease K; Kong FM
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):103-10. PubMed ID: 17363189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable Stage III non-small cell lung cancer using helical tomotherapy.
    Bral S; Duchateau M; Versmessen H; Engels B; Tournel K; Vinh-Hung V; De Ridder M; Schallier D; Storme G
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1352-9. PubMed ID: 20056350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas.
    Fukumoto S; Shirato H; Shimzu S; Ogura S; Onimaru R; Kitamura K; Yamazaki K; Miyasaka K; Nishimura M; Dosaka-Akita H
    Cancer; 2002 Oct; 95(7):1546-53. PubMed ID: 12237924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
    Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
    Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Ciammella P; Franco P; Mantovani C; Borasio P; Scagliotti GV; Ragona R
    Lung Cancer; 2010 Apr; 68(1):72-7. PubMed ID: 19556022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy alone in elderly patients with medically inoperable stage IIIA and IIIB non-small cell lung cancer.
    Tombolini V; Bonanni A; Donato V; Raffetto N; Santarelli M; Valeriani M; Enrici RM
    Anticancer Res; 2000; 20(6C):4829-33. PubMed ID: 11205228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involved-field radiotherapy is effective for patients 70 years old or more with early stage non-small cell lung cancer.
    Yu HM; Liu YF; Yu JM; Liu J; Zhao Y; Hou M
    Radiother Oncol; 2008 Apr; 87(1):29-34. PubMed ID: 18237795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer.
    Gridley DS; Bonnet RB; Bush DA; Franke C; Cheek GA; Slater JD; Slater JM
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):759-66. PubMed ID: 15465192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.